Rho Ventures
VC Fund
New York, United States
Rho Ventures is a VC fund in New York focused on Software and Biotechnology. We invest across most high growth sectors of today’s economy and have developed deep expertise and relationships in Information Technology, Communications, New Media, Healthcare and New Energy.Since 1981, Rho Ventures has been investing in innovators that redefine the status quo. Rho’s investment philosophy does not fit a conventional model,much like the visionary innovators we back. We believe that formulaic approaches to investing lead to risk averse strategies that stifle innovation and differentiation. We actively avoid restrictive boundaries around ideas, growth opportunities and entrepreneur profiles. To find extraordinary opportunities, we are not bound by a particular stage of investment and do not shy away from contrarian ideas.We believe that great companies take root in unconventional places and that successful entrepreneurs frequently break the mold. The ideas we back come from a variety of sources: an MBA student who is trying to change new media advertising practices; an experienced entrepreneur seeking to commercialize a disruptive biofuels technology; or an executive looking to spin out and develop an abandoned asset developed by a pharmaceutical company. We are seasoned investors who have backed more than 200 companies through multiple cycles. Identifying interesting opportunities and providing capital is just the beginning. We offer deep-sector expertise in today’s high-growth markets, but we do not let any one area of knowledge guide our overall investment strategy.Ultimately, we look for entrepreneurs who we can help make very big waves, not just stir the waters and move on to the next venture.
- Total investments:
- 121
- Last investment:
- Lead investor:
- 26%
- Fund size:
- $425M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Rho Ventures invests in
Stages Rho Ventures invests in
Countries Rho Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 15 (12%)
- Biotechnology 14 (12%)
- Health Care 13 (11%)
- Telecommunications 10 (8%)
- Manufacturing 9 (7%)
Stage
- Series B 23 (19%)
- Series A 20 (17%)
- Funding Round 18 (15%)
- Series C 17 (14%)
- Series D 15 (12%)
Country
- United States 72 (60%)
- Canada 4 (3%)
- United Kingdom 2 (2%)
- Israel 1 (1%)
- Australia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Patrick Wack
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Doug McCormick
Venture Partner
|
Venture Partner | Total investments: 4 | Find email | |
Jeff Martin
Partner and General Counsel
|
Partner and General Counsel | Total investments: 0 | Find email | |
Joshua Ruch
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 16 | Find email | |
Mark Roehrenbeck
Associate
|
Associate | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Fondo
|
Fondo helps with bookkeeping and beyond so founders can grow their businesses with more resources. The company strives to help founders build an enduring business by taking work off of their plate, providing them with the data needed to make key business decisions, and making sure the startup is in compliance at the state and federal level. | $7M / Seed / Nov 22, 2024 | |
Aluna
|
Aluna provides a respiratory management system for children and adults with chronic lung conditions including asthma, cystic fibrosis and COPD. | $15.3M / Series B / Jan 31, 2023 | |
Blocknative
|
Blocknative is a provider of real-time blockchain transaction management and monitoring solutions for public blockchain networks. It was founded in 2018 and is based in San Francisco, California. | $15M / Series A / Dec 15, 2022 | |
Leal Health
|
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to executepatient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn. | $20M / Series A / Feb 07, 2022 | |
Feel
|
Feel connects brands and personal shoppers by providing real-life virtual product demonstrations and online shopping experience. | $4M / Seed / Mar 01, 2021 | |
|
Leal Health
|
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to executepatient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn. | $5M / Series A / Feb 22, 2021 | |
Suzy
|
Headquartered in New York City, Suzy is a technology platform that harnesses collective insights from millions of consumers worldwide to deliver real-time intelligence. Suzy is the voice of consumers, helping companies validate critical assumptions so they can create compelling new products, develop effective marketing strategies, and validatedirect offers that increase conversion, improve path-to-purchase, and drive growth. The company is backed by Foundry Group Tribeca Venture Partners, and The Durant Company among others, and trusted by Fortune 500s and challenger brands alike - including Netflix, Coca-Cola, Procter & Gamble, Johnson & Johnson, Citibank, Verizon, Nintendo, and Nestle, among others. Millions of business decisions are made every day based on untested assumptions, Suzy gives companies an unprecedented direct line of communication to their customers on demand; helping them instantly validate anything, anytime, anywhere. | $16M / Series C / Sep 01, 2020 | |
Vertoe
|
Vertoe is the world's leading on-demand, short-term storage service that offers 500+ secure locations to store your bags and personal items across 50+ cities. With rates starting at a minimum of $5.95 per day coupled with the best in industry insurance of $5000, you can secure your items affordably and get the freedom to experience anywhere,anytime instantly. | $2M / Convertible Note / Dec 12, 2019 | |
Dashlane
|
Dashlane is an award-winning app that lets you access and share business and personal passwords anytime, anywhere. The app works across every major operating system and browser — so every user can enjoy a simpler, safer internet. Our team in Paris, New York, and Lisbon is united by our passion for improving the digital experience and the beliefthat with the right tools, we can help everyone simplify their online lives. Dashlane has empowered over 15 million users and 20,000 businesses in 180 countries to enjoy a faster, simpler, and more secure internet. | $110M / Series D / May 30, 2019 | |
Enerkem
|
Enerkem is a cleantech company transforming waste into transportation biofuels, renewable chemicals, and everyday products. Through the combination of a proprietary thermochemical technology platform and community-based advanced facilities, Enerkem addresses the challenges of oil dependence and waste disposal.Enerkem has validated itsproprietary technology over a period of 10 years using the solid waste from numerous municipalities and other types of feedstock. The company’s process and business model are designed to profitably produce cellulosic ethanol from a large municipal solid waste supply. Enerkem is a private company founded in 2000 by its current senior management. It is majority-owned by institutional, clean-technology and industrial investors, including Rho Ventures, Waste Management, Braemar Energy Ventures, Investissement Québec, Valero, Cycle Capital, The Westly Group, Fonds de solidarité FTQ, and Fondaction CSN.Headquartered in Montreal, Canada, Enerkem has 170 employees in Canada and the United States. | $76.3M / Corporate Round / Apr 17, 2019 | |
| See all 121 investments → | |||
Co-Investors
Sevin Rosen Funds
14 deals together
CenterPoint Venture Partners
11 deals together
Braemar Energy Ventures
9 deals together
Care Capital
9 deals together
HealthCare Ventures
8 deals together
MedImmune Ventures
6 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Rho Ventures invest in?
Rho Ventures invests primarily in Software, Biotechnology and Health Care startups, most often at Series B and Series A stage. Most of the 121 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Rho Ventures?
Public channels for Rho Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Rho Ventures?
The team at Rho Ventures includes Patrick Wack (Venture Partner), Doug McCormick (Venture Partner) and Jeff Martin (Partner and General Counsel), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
